Scynexis (SCYX) Change in Inventory (2022 - 2023)

Scynexis (SCYX) posted Change in Inventory of $1.5 million for Q4 2023, down 48.23% on a QoQ basis from $2.8 million in Q3 2023, and up 60.66% year-over-year from $910000.0 in Q4 2022.

Scynexis (SCYX) Change in Inventory (2022 - 2023) Analysis & Trends

Scynexis' Change in Inventory history runs 2 years deep, the most recent figure standing at $1.5 million for Q4 2023.

  • Quarterly Change in Inventory rose 60.66% year-over-year to $1.5 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $1.5 million (down 82.38% YoY) and the FY2023 annual result came in at $8.8 million, up 1929.59% from the prior year.
  • Change in Inventory was $1.5 million for Q4 2023 at Scynexis, down from $2.8 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.8 million in Q3 2023 and bottomed at -$797000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -93.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 114.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 119.24 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 123.00 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -4.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Scynexis 21.55 Mn -15.20 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.46 Mn
Dec 31, 2023 1.46 Mn
Sep 30, 2023 2.82 Mn
Sep 30, 2023 2.82 Mn
Jun 30, 2023 1.86 Mn
Jun 30, 2023 1.86 Mn
Mar 31, 2023 2.71 Mn
Mar 31, 2023 2.71 Mn
Dec 31, 2022 910,000.00
Dec 31, 2022 910,000.00
Sep 30, 2022 -797,000.00
Sep 30, 2022 -797,000.00